Valsartan oral solution for high blood pressure in children
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if an oral solution of valsartan safely lowers blood pressure in children and teens ages 6 to 17. It may be an option if your child has high blood pressure and qualifies based on age, weight, and blood pressure level.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 and 17 years old.
- Your child must weigh between 40 and 352 pounds (18 to 160 kg).
- Your child must have been diagnosed with essential high blood pressure (not caused by another condition) and have a blood pressure at or above the 95th percentile for their age, sex, and height.
- Your child must have safe blood, liver, and kidney function as shown by recent lab tests.
- A parent or guardian must give permission, and the child must agree to join (if old enough).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination blood pressure medicine called CKD-202A. It is for adults with high blood pressure who have not had other treatments or conditions that could affect the results.
This study tests a new pill that combines two blood pressure medicines to see if it can lower blood pressure more effectively in people with moderate to severe high blood pressure. If you have high blood pressure that is not well controlled, this trial might help you find a new treatment option.
This study tests five new medicines to see if they can lower blood pressure in people with mild to moderate essential hypertension. It may help you if your blood pressure is not well controlled and you are willing to take the study medicine for a period of time.
This trial tests whether a blood pressure medicine called valsartan can help protect the lungs and heart in people with a specific type of pulmonary hypertension (Group 1 PAH). If you have PAH and are stable enough to walk 50 meters, you may be able to join.
This trial tests whether timing blood pressure medications (based on your natural daily body rhythms) can improve blood pressure control. It’s designed for adults with moderately high blood pressure and focuses on who may benefit from a more precise schedule.
This study tests how sacubitril/valsartan may affect heart function in people with high blood pressure, and whether results differ by body size (BMI). You may benefit by getting closer heart monitoring, though it depends on whether you fit the safety and medical criteria.
Hear when a new Essential Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.